A.Prof Frank Gaillard
on February 16, 2017
Pseudoprogression is typically encountered in the first 6 months following completion of radiotherapy and is particularly common in MGMT methylate...”
View full size version of Glioblastoma IDH wild-type (thalamic with pseudoprogression)
See the case: Glioblastoma IDH wild-type (thalamic with pseudoprogression)
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.